{"id":"W3162915930","doi":"10.1016/j.msard.2021.103012","title":"The effectiveness of natalizumab vs fingolimod–A comparison of international registry studies","year":2021,"lang":"en","type":"article","venue":"Multiple Sclerosis and Related Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"Cegep de Saint Jerome; Université de Montréal; Hôpital Notre-Dame; Centre intégré de santé et de services sociaux de Chaudière-Appalaches","funders":"National Health and Medical Research Council; Centre Hospitalier Universitaire de Rennes; Sanofi Genzyme; Multiple Sclerosis Society; Centre Hospitalier Universitaire de Nice; Sanofi; Université Claude Bernard Lyon 1; Institut National de la Santé et de la Recherche Médicale; Canadian Institutes of Health Research; Centre Hospitalier Universitaire de Toulouse; Multiple Sclerosis Society of Canada; Fondation pour l'Aide à la Recherche sur la Sclérose en Plaques; Novartis; Celgene; Fondazione Italiana Sclerosi Multipla; Biogen; MedDay Pharmaceuticals; GlaxoSmithKline; Merck; Teva Pharmaceutical Industries; Université de Lorraine; Centre Hospitalier Universitaire de Bordeaux; Hospices Civils de Lyon; Agence Nationale de la Recherche; Roche","keywords":"Fingolimod; Natalizumab; Medicine; Multiple sclerosis; Hazard ratio; Internal medicine; Immunology; Confidence interval","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.173395,0.001402443,0.005453499,0.009131624,0.0006540425,0.00581292,0.002605308,0.001672139,0.003924221],"category_scores_gemma":[0.2719056,0.001095952,0.0116709,0.01220646,0.001469076,0.004580921,0.003604302,0.001463216,0.0004984608],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001506278,"about_ca_system_score_gemma":0.001938433,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001388242,"about_ca_topic_score_gemma":0.001507381,"domain_scores_codex":[0.7962865,0.1427955,0.03585872,0.01175592,0.01104937,0.002254049],"domain_scores_gemma":[0.6244022,0.2048845,0.1123203,0.03550991,0.02053154,0.002351524],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1067409,0.000516099,0.5554369,0.02215641,0.2208114,0.0004261284,0.002507002,0.001994444,0.0008655086,0.002739797,0.003809331,0.08199609],"study_design_scores_gemma":[0.01519031,0.009122343,0.6064484,0.01191368,0.3289532,0.001780665,0.003679702,0.002376102,0.002377482,0.002303225,0.01547544,0.0003795137],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7695534,0.1936204,0.00727432,0.002409218,0.0007781958,0.001696735,0.01376746,0.0001565702,0.01074363],"genre_scores_gemma":[0.9717268,0.01598752,0.002165268,0.0004985764,0.000358317,0.001290426,0.007557949,0.0001307768,0.0002843822],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.173395,"threshold_uncertainty_score":0.9170115,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04998136824734042,"score_gpt":0.3325948420056046,"score_spread":0.2826134737582642,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}